Metastatic Gastric Adenocarcinoma Completed Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03918499IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerTreatment